Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARVINAS, INC.ARVN · Entity 5355 | Chief Financial Officer | February 23, 2024 | February 27, 2024 |
| HOOKIPA Pharma Inc.HOOK · Entity 15295 | Director | July 22, 2024 | July 24, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARVINAS, INC.
Report date February 23, 2024 · Filed February 27, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 181,916 |
Reported balance
After 2024-02-23 transaction · row 1
1 source rowRow 1 · 2024-02-23 · Sale · Disposed 1,702 · Balance 181,916 F1: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.
HOOKIPA Pharma Inc.
Report date July 22, 2024 · Filed July 24, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.44 · Expires 2034-07-22 | Direct | 9,800 |
Reported balance
After 2024-07-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-07-22 · Grant · Acquired 9,800 · Balance 9,800 F1: The shares subject to this option will vest in thirty-six equal monthly installments commencing July 22, 2024, subject to Reporting Person's continuous service through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to this option will vest in thirty-six equal monthly installments commencing July 22, 2024, subject to Reporting Person's continuous service through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2020 Filed Mar 24, 2020 07:30 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 8,030 | $16.00 | $128,480.00 |
DisclosureSEC source: 0001209191-20-020803 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:35 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionRestricted Stock Units · Derivative | 4,791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020795 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,374 Underlying: Common Stock · 4,791 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. F4 · derivative.expiration_date: On March 1, 2019, the reporting person was granted 19,165 Restricted Stock Units, vesting in four equal annual installments beginning March 1, 2020. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:35 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 1,514 | $37.61 | $56,941.54 |
DisclosureSEC source: 0001209191-20-020795 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,392 F2 · shares: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units. F3 · price: The broker sold shares of Arvinas Common Stock for certain Arvinas employees following the vesting of previously granted Restricted Stock Units, including the Common Stock reported on this Form 4 by the Reporting Person, at an average price of $37.61. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:35 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 4,791 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-020795 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 17:29 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $47.38 | $0.00 |
DisclosureSEC source: 0001209191-20-014640 · doc4.xml · derivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-02-26 F1 · derivative.exercise_date: This option award was granted on February 27, 2020. 1/4 of the shares underlying the award shall vest on February 27, 2021, with the remainder of the shares vesting in equal monthly installments following February 27, 2021 through February 27, 2024. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 18:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 30 | $54.10 | $1,623.00 |
DisclosureSEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 5 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,115 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 18:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 1,302 | $52.86 | $68,823.72 |
DisclosureSEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,145 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.79 to $53.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 18:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 1,880 | $52.30 | $98,324.00 |
DisclosureSEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,447 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.73 to $52.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 18:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 2,190 | $50.97 | $111,624.30 |
DisclosureSEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,327 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.48 to $51.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 18:00 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 4,598 | $49.97 | $229,762.06 |
DisclosureSEC source: 0001209191-20-008425 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,517 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.41 to $50.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 17:45 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 10,000 | $32.00 | $320,000.00 |
DisclosureSEC source: 0001209191-19-057640 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,115 F1 · kind: The sales reported in this Form 4 were effected pursuant to Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. Read SEC document |
| August 07, 2019 Filed Aug 9, 2019 16:04 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 2,058 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045324 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,142 Underlying: Common Stock · 2,058 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| August 07, 2019 Filed Aug 9, 2019 16:04 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 2,212 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045324 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,948 Underlying: Common Stock · 2,212 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020. Read SEC document |
| August 07, 2019 Filed Aug 9, 2019 16:04 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionStock Option (right to buy) · Derivative | 1,980 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-19-045324 · doc4.xml · derivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,980 shares Expires 2028-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
| August 07, 2019 Filed Aug 9, 2019 16:04 UTC | ARVINAS, INC. ARVN · Entity 5355 | Exercise / conversionCommon Stock | 6,250 | $16.00 | $100,000.00 |
DisclosureSEC source: 0001209191-19-045324 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 17:43 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 60 | $28.03 | $1,681.80 |
DisclosureSEC source: 0000899243-19-020690 · doc4.xml · nonDerivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,865 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 17:43 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 1,108 | $27.04 | $29,960.32 |
DisclosureSEC source: 0000899243-19-020690 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,925 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.88 to $27.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 17:43 UTC | ARVINAS, INC. ARVN · Entity 5355 | SaleCommon Stock | 10,777 | $26.13 | $281,603.01 |
DisclosureSEC source: 0000899243-19-020690 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,033 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 27, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.75 to $26.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 18:24 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 87,752 | $0.00 Strike: $19.36 | $0.00 |
DisclosureSEC source: 0000899243-19-006227 · doc4.xml · derivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,752 Underlying: Common Stock · 87,752 shares Expires 2029-02-28 F3 · derivative.exercise_date: This option award was granted on March 1, 2019. 1/4 of the shares underlying the award shall vest on March 1, 2020, with the remainder of the shares vesting in equal monthly installments following March 1, 2020 through March 1, 2023. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 18:24 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantRestricted Stock Units · Derivative | 19,165 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006227 · doc4.xml · derivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,165 Underlying: Common Stock · 19,165 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning March 1, 2020. F2 · derivative.expiration_date: The restricted stock units vest in four equal annual installments beginning March 1, 2020. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 17:21 UTC | ARVINAS, INC. ARVN · Entity 5355 | ConversionSeries C Preferred Stock · Derivative | 2,368 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-026071 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 728 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.exercise_date: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.expiration_date: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 17:21 UTC | ARVINAS, INC. ARVN · Entity 5355 | ConversionSeries B Preferred Stock · Derivative | 15,007 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-026071 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.exercise_date: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · derivative.expiration_date: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 17:21 UTC | ARVINAS, INC. ARVN · Entity 5355 | ConversionCommon Stock | 5,345 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-026071 · doc4.xml · nonDerivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,810 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: On October 1, 2018, the Series B Preferred Stock and Series C Preferred Stock converted into Common Stock on a 3.25-for-one basis, upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock and Series C Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 17:21 UTC | ARVINAS, INC. ARVN · Entity 5355 | PurchaseCommon Stock | 1,600 | $16.00 | $25,600.00 |
DisclosureSEC source: 0000899243-18-026071 · doc4.xml · nonDerivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,465 F1 · shares: Reflects shares of the Issuer's Common Stock that were purchased in connection with the Issuer's initial public offering. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 27,330 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 6 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,330 Underlying: Common Stock · 27,330 shares Expires 2028-09-25 F6 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on June 28, 2019, with the remainder of the shares vesting in equal monthly installments following June 28, 2019 through June 28, 2022. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 81,770 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 5 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,770 Underlying: Common Stock · 81,770 shares Expires 2028-09-25 F5 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on March 31, 2019, with the remainder of the shares vesting in equal monthly installments following March 31, 2019 through March 31, 2022. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 5,200 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 4 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 Underlying: Common Stock · 5,200 shares Expires 2028-09-25 F4 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award shall vest on January 1, 2019, with the remainder of the shares vesting in equal monthly installments following January 1, 2019 through January 1, 2022. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 15,160 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 3 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,160 Underlying: Common Stock · 15,160 shares Expires 2028-09-25 F3 · derivative.exercise_date: This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of January 1, 2017, with the remainder of the shares vesting in equal monthly installments following January 1, 2017 through January 1, 2020. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 31,710 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 2 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,710 Underlying: Common Stock · 31,710 shares Expires 2028-09-25 F2 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
| September 26, 2018 Filed Sep 28, 2018 20:43 UTC | ARVINAS, INC. ARVN · Entity 5355 | GrantStock Option (right to buy) · Derivative | 1,980 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-18-025551 · doc4.xml · derivative · entry 1 Cassidy Sean A · CIK 0001421914 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,980 Underlying: Common Stock · 1,980 shares Expires 2028-09-25 F1 · derivative.exercise_date: This option award was granted on September 26, 2018, and the shares underlying the award were fully vested upon grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.